Gideon Capital Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-783	Closed	-$145K	–	474
2016 Q4	$145K	Buy	+783	New	+$145K	0.09%	383